ID   NOS2_RAT                Reviewed;        1147 AA.
AC   Q06518; O35765; O35766; O60591; O60604; P97774; Q63267; Q64005; Q64558;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   24-JUL-2024, entry version 214.
DE   RecName: Full=Nitric oxide synthase, inducible;
DE            EC=1.14.13.39 {ECO:0000250|UniProtKB:P35228};
DE   AltName: Full=Inducible NO synthase;
DE            Short=Inducible NOS;
DE            Short=iNOS;
DE   AltName: Full=NOS type II;
DE   AltName: Full=Peptidyl-cysteine S-nitrosylase NOS2;
GN   Name=Nos2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Vascular smooth muscle;
RX   PubMed=7680561; DOI=10.1006/bbrc.1993.1188;
RA   Nunokawa Y., Ishida N., Tanaka S.;
RT   "Cloning of inducible nitric oxide synthase in rat vascular smooth muscle
RT   cells.";
RL   Biochem. Biophys. Res. Commun. 191:89-94(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Pancreatic islet;
RX   PubMed=7540573; DOI=10.2337/diab.44.7.753;
RA   Karlsen A.E., Andersen H.U., Vissing H., Larsen P.M., Fey S.J.,
RA   Cuartero B.G., Madsen O.D., Petersen J.S., Mortensen S.B.,
RA   Mandrup-Poulsen T., Boel E., Nerup J.;
RT   "Cloning and expression of cytokine-inducible nitric oxide synthase cDNA
RT   from rat islets of Langerhans.";
RL   Diabetes 44:753-758(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Astrocyte;
RX   PubMed=7513765; DOI=10.1002/jnr.490370313;
RA   Galea E., Reis D.J., Feinstein D.L.;
RT   "Cloning and expression of inducible nitric oxide synthase from rat
RT   astrocytes.";
RL   J. Neurosci. Res. 37:406-414(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=7693462; DOI=10.1111/j.1432-1033.1993.tb18215.x;
RA   Adachi H., Iida S., Oguchi S., Ohshima H., Suzuki H., Nagasaki K.,
RA   Kawasaki H., Sugimura T., Esumi H.;
RT   "Molecular cloning of a cDNA encoding an inducible calmodulin-dependent
RT   nitric-oxide synthase from rat liver and its expression in COS 1 cells.";
RL   Eur. J. Biochem. 217:37-43(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Hepatocyte;
RX   PubMed=7682072; DOI=10.1006/bbrc.1993.1283;
RA   Wood E.R., Berger H. Jr., Sherman P.A., Lapetina E.G.;
RT   "Hepatocytes and macrophages express an identical cytokine inducible nitric
RT   oxide synthase gene.";
RL   Biochem. Biophys. Res. Commun. 191:767-774(1993).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Aorta;
RX   PubMed=7519448; DOI=10.1016/0167-4781(94)90196-1;
RA   Geng Y.J., Almquist M., Hansson G.K.;
RT   "cDNA cloning and expression of inducible nitric oxide synthase from rat
RT   vascular smooth muscle cells.";
RL   Biochim. Biophys. Acta 1218:421-424(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Kosuga K., Yui Y., Hattori R., Sase K., Eizawa H., Aoyama T., Inoue R.,
RA   Sasayama S.;
RT   "Cloning of an inducible nitric oxide synthase from rat polymorphonuclear
RT   neutrophils.";
RL   Endothelium 2:217-221(1994).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8913516; DOI=10.1248/bpb.19.1374;
RA   Tsutsumishita Y., Kawai Y., Takahara H., Onda T., Miyoshi J., Futaki S.,
RA   Niwa M.;
RT   "Sequence analysis of inducible nitric oxide synthase in rat kidney, lung,
RT   and uterus.";
RL   Biol. Pharm. Bull. 19:1374-1376(1996).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9851365; DOI=10.1006/niox.1998.0184;
RA   Adams V., Krabbes S., Jiang H., Yu J., Rahmel A., Gielen S., Schuler G.,
RA   Hambrecht R.;
RT   "Complete coding sequence of inducible nitric oxide synthase from human
RT   heart and skeletal muscle of patients with chronic heart failure.";
RL   Nitric Oxide 2:242-249(1998).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 426-788.
RC   STRAIN=Dahl/Rapp salt sensitive strain; TISSUE=Vascular smooth muscle;
RX   PubMed=9535415; DOI=10.1161/01.hyp.31.4.918;
RA   Chen P.Y., Gladish R.D., Sanders P.W.;
RT   "Vascular smooth muscle nitric oxide synthase anomalies in Dahl/Rapp salt-
RT   sensitive rats.";
RL   Hypertension 31:918-924(1998).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 509-740.
RC   STRAIN=Wistar; TISSUE=Renal glomerulus;
RA   Saura M., Zaragoza C., Martinez-Dalmau R., Perez-Sala D., Lamas S.;
RT   "Advances in the studies of NO synthesis regulation in mesanglial cells.";
RL   Nefrologia 16:35-39(1996).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 479-655.
RC   STRAIN=Sprague-Dawley; TISSUE=Renal glomerulus;
RX   PubMed=7516453; DOI=10.1038/ki.1994.135;
RA   Morrissey J.J., McCracken R., Kaneto H., Vehaskari M., Montani D.,
RA   Klahr S.;
RT   "Location of an inducible nitric oxide synthase mRNA in the normal
RT   kidney.";
RL   Kidney Int. 45:998-1005(1994).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 420-479.
RC   TISSUE=Myocardium;
RA   Michel T., Balligand J.-L.;
RT   "Isolation and characterization of iNOS from rat cardiocytes.";
RL   Submitted (SEP-1994) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-564 AND TYR-572, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
CC   -!- FUNCTION: Produces nitric oxide (NO) which is a messenger molecule with
CC       diverse functions throughout the body. In macrophages, NO mediates
CC       tumoricidal and bactericidal actions. Also has nitrosylase activity and
CC       mediates cysteine S-nitrosylation of cytoplasmic target proteins such
CC       PTGS2/COX2. As component of the iNOS-S100A8/9 transnitrosylase complex
CC       involved in the selective inflammatory stimulus-dependent S-
CC       nitrosylation of GAPDH implicated in regulation of the GAIT complex
CC       activity and probably multiple targets including ANXA5, EZR, MSN and
CC       VIM. Involved in inflammation, enhances the synthesis of pro-
CC       inflammatory mediators such as IL6 and IL8.
CC       {ECO:0000250|UniProtKB:P29477, ECO:0000250|UniProtKB:P35228}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + 2 L-arginine + 3 NADPH + 4 O2 = 4 H2O + 2 L-citrulline
CC         + 3 NADP(+) + 2 nitric oxide; Xref=Rhea:RHEA:19897,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16480, ChEBI:CHEBI:32682, ChEBI:CHEBI:57743,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.14.13.39;
CC         Evidence={ECO:0000250|UniProtKB:P35228};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19898;
CC         Evidence={ECO:0000250|UniProtKB:P35228};
CC   -!- COFACTOR:
CC       Name=heme b; Xref=ChEBI:CHEBI:60344;
CC         Evidence={ECO:0000250|UniProtKB:P35228};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000250|UniProtKB:P29476};
CC       Note=Binds 1 FAD. {ECO:0000250|UniProtKB:P29476};
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000250|UniProtKB:P35228};
CC       Note=Binds 1 FMN. {ECO:0000250|UniProtKB:P35228};
CC   -!- COFACTOR:
CC       Name=(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin;
CC         Xref=ChEBI:CHEBI:59560; Evidence={ECO:0000250|UniProtKB:P35228};
CC       Note=Tetrahydrobiopterin (BH4). May stabilize the dimeric form of the
CC       enzyme. {ECO:0000250|UniProtKB:P35228};
CC   -!- ACTIVITY REGULATION: Not stimulated by calcium/calmodulin. Aspirin
CC       inhibits expression and function of this enzyme and effects may be
CC       exerted at the level of translational/post-translational modification
CC       and directly on the catalytic activity (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. Interacts with NHERF1. Interacts with GAPDH;
CC       induced by oxidatively-modified low-densitity lipoprotein (LDL(ox)).
CC       Interacts with S100A8 and S100A9 to form the iNOS-S100A8/9
CC       transnitrosylase complex. Interacts with SPSB1, SPSB2 and SPSB4.
CC       Interacts with ELOC and CUL5 in the presence of SPSB1 or SPSB2 or
CC       SPSB4. Forms a complex with ASL, ASS1 and HSP90AA1; the complex
CC       regulates cell-autonomous L-arginine synthesis and citrulline recycling
CC       while channeling extracellular L-arginine to nitric oxide synthesis
CC       pathway. {ECO:0000250|UniProtKB:P29477}.
CC   -!- INTERACTION:
CC       Q06518; Q7TQN4: Rela; NbExp=3; IntAct=EBI-15919967, EBI-1187180;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:P35228}. Note=Localizes as discrete foci
CC       scattered throughout the cytosol and in the presence of SPSB1 and
CC       SPSB4, exhibits a more diffuse cytosolic localization.
CC       {ECO:0000250|UniProtKB:P35228}.
CC   -!- TISSUE SPECIFICITY: In normal kidney, expressed primarily in the
CC       medullary thick ascending limb, with minor amounts in the medullary
CC       collecting duct and vasa recta bundle.
CC   -!- INDUCTION: By interferon gamma and lipopolysaccharides (LPS).
CC   -!- PTM: Polyubiquitinated; mediated by SPSB1, SPSB2 and SPSB4, leading to
CC       proteasomal degradation. {ECO:0000250|UniProtKB:P35228}.
CC   -!- SIMILARITY: Belongs to the NOS family. {ECO:0000305}.
CC   -!- CAUTION: sequence Was originally thought to originate from human but
CC       appears to be from rat. {ECO:0000305|PubMed:9851365}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D14051; BAA03138.1; -; mRNA.
DR   EMBL; U26686; AAA85861.1; -; mRNA.
DR   EMBL; U03699; AAC13747.1; -; mRNA.
DR   EMBL; D12520; BAA02090.1; -; mRNA.
DR   EMBL; L12562; AAA41720.1; -; mRNA.
DR   EMBL; X76881; CAA54208.1; -; mRNA.
DR   EMBL; D44591; BAA07994.1; -; mRNA.
DR   EMBL; D83661; BAA12035.1; -; mRNA.
DR   EMBL; AF049656; AAC83553.1; -; mRNA.
DR   EMBL; AF051164; AAC83554.1; -; mRNA.
DR   EMBL; AF006619; AAC16401.1; -; mRNA.
DR   EMBL; AF006620; AAC16402.1; -; mRNA.
DR   EMBL; U48829; AAB18620.1; -; mRNA.
DR   EMBL; S71597; AAB31028.2; -; mRNA.
DR   EMBL; L36063; AAC02242.1; -; mRNA.
DR   PIR; I53165; I53165.
DR   PIR; I56575; I56575.
DR   PIR; JC5027; JC5027.
DR   PIR; S38253; S38253.
DR   PIR; S47647; S47647.
DR   RefSeq; NP_036743.3; NM_012611.3.
DR   AlphaFoldDB; Q06518; -.
DR   SMR; Q06518; -.
DR   CORUM; Q06518; -.
DR   DIP; DIP-59942N; -.
DR   IntAct; Q06518; 1.
DR   STRING; 10116.ENSRNOP00000067662; -.
DR   BindingDB; Q06518; -.
DR   ChEMBL; CHEMBL3051; -.
DR   iPTMnet; Q06518; -.
DR   PhosphoSitePlus; Q06518; -.
DR   PaxDb; 10116-ENSRNOP00000067662; -.
DR   Ensembl; ENSRNOT00055043587; ENSRNOP00055035578; ENSRNOG00055025134.
DR   Ensembl; ENSRNOT00060033771; ENSRNOP00060027661; ENSRNOG00060019106.
DR   GeneID; 24599; -.
DR   KEGG; rno:24599; -.
DR   AGR; RGD:3185; -.
DR   CTD; 4843; -.
DR   RGD; 3185; Nos2.
DR   eggNOG; KOG1158; Eukaryota.
DR   InParanoid; Q06518; -.
DR   OrthoDB; 276396at2759; -.
DR   PhylomeDB; Q06518; -.
DR   BRENDA; 1.14.13.39; 5301.
DR   Reactome; R-RNO-1222556; ROS and RNS production in phagocytes.
DR   Reactome; R-RNO-392154; Nitric oxide stimulates guanylate cyclase.
DR   Reactome; R-RNO-9033241; Peroxisomal protein import.
DR   PRO; PR:Q06518; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030863; C:cortical cytoskeleton; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0003779; F:actin binding; IDA:RGD.
DR   GO; GO:0034618; F:arginine binding; ISO:RGD.
DR   GO; GO:0008013; F:beta-catenin binding; IPI:RGD.
DR   GO; GO:0045296; F:cadherin binding; IPI:RGD.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0008603; F:cAMP-dependent protein kinase regulator activity; IDA:RGD.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; ISO:RGD.
DR   GO; GO:0010181; F:FMN binding; ISO:RGD.
DR   GO; GO:0020037; F:heme binding; ISO:RGD.
DR   GO; GO:0051879; F:Hsp90 protein binding; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0050661; F:NADP binding; IEA:InterPro.
DR   GO; GO:0004517; F:nitric-oxide synthase activity; IDA:RGD.
DR   GO; GO:0050998; F:nitric-oxide synthase binding; IPI:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0034617; F:tetrahydrobiopterin binding; ISO:RGD.
DR   GO; GO:0006527; P:arginine catabolic process; ISO:RGD.
DR   GO; GO:0001974; P:blood vessel remodeling; IMP:RGD.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; IDA:MGI.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0071285; P:cellular response to lithium ion; IEP:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IDA:MGI.
DR   GO; GO:0071461; P:cellular response to redox state; IEP:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0071346; P:cellular response to type II interferon; ISO:RGD.
DR   GO; GO:0071305; P:cellular response to vitamin D; IEP:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0019934; P:cGMP-mediated signaling; IDA:RGD.
DR   GO; GO:0007623; P:circadian rhythm; ISO:RGD.
DR   GO; GO:0042742; P:defense response to bacterium; ISS:UniProtKB.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; IEP:RGD.
DR   GO; GO:0001935; P:endothelial cell proliferation; IEP:RGD.
DR   GO; GO:0007199; P:G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger; IDA:RGD.
DR   GO; GO:0016137; P:glycoside metabolic process; IEP:RGD.
DR   GO; GO:0006954; P:inflammatory response; IBA:GO_Central.
DR   GO; GO:0035556; P:intracellular signal transduction; IMP:RGD.
DR   GO; GO:0045776; P:negative regulation of blood pressure; IBA:GO_Central.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; ISO:RGD.
DR   GO; GO:0006809; P:nitric oxide biosynthetic process; IDA:RGD.
DR   GO; GO:0007263; P:nitric oxide mediated signal transduction; IBA:GO_Central.
DR   GO; GO:0018119; P:peptidyl-cysteine S-nitrosylation; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; ISS:UniProtKB.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; ISS:UniProtKB.
DR   GO; GO:0051712; P:positive regulation of killing of cells of another organism; ISO:RGD.
DR   GO; GO:0032310; P:prostaglandin secretion; ISS:UniProtKB.
DR   GO; GO:0008217; P:regulation of blood pressure; IMP:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:1900015; P:regulation of cytokine production involved in inflammatory response; ISS:UniProtKB.
DR   GO; GO:0050796; P:regulation of insulin secretion; ISO:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:0009617; P:response to bacterium; ISO:RGD.
DR   GO; GO:0071548; P:response to dexamethasone; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0009750; P:response to fructose; IEP:RGD.
DR   GO; GO:0009749; P:response to glucose; IEP:RGD.
DR   GO; GO:0009725; P:response to hormone; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; ISO:RGD.
DR   GO; GO:0035902; P:response to immobilization stress; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0090649; P:response to oxygen-glucose deprivation; IEP:RGD.
DR   GO; GO:0034612; P:response to tumor necrosis factor; IMP:RGD.
DR   GO; GO:0048384; P:retinoic acid receptor signaling pathway; IEP:RGD.
DR   GO; GO:0006801; P:superoxide metabolic process; ISS:UniProtKB.
DR   CDD; cd00795; NOS_oxygenase_euk; 1.
DR   Gene3D; 3.40.50.360; -; 2.
DR   Gene3D; 6.10.250.410; -; 1.
DR   Gene3D; 3.90.440.10; Nitric Oxide Synthase;Heme Domain;Chain A domain 2; 1.
DR   Gene3D; 3.40.50.80; Nucleotide-binding domain of ferredoxin-NADP reductase (FNR) module; 1.
DR   Gene3D; 2.40.30.10; Translation factors; 1.
DR   InterPro; IPR003097; CysJ-like_FAD-binding.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR001094; Flavdoxin-like.
DR   InterPro; IPR008254; Flavodoxin/NO_synth.
DR   InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR   InterPro; IPR029039; Flavoprotein-like_sf.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR023173; NADPH_Cyt_P450_Rdtase_alpha.
DR   InterPro; IPR050607; NOS.
DR   InterPro; IPR044943; NOS_dom_1.
DR   InterPro; IPR044940; NOS_dom_2.
DR   InterPro; IPR044944; NOS_dom_3.
DR   InterPro; IPR012144; NOS_euk.
DR   InterPro; IPR004030; NOS_N.
DR   InterPro; IPR036119; NOS_N_sf.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   PANTHER; PTHR43410; NITRIC OXIDE SYNTHASE OXYGENASE; 1.
DR   PANTHER; PTHR43410:SF1; NITRIC OXIDE SYNTHASE OXYGENASE; 1.
DR   Pfam; PF00667; FAD_binding_1; 1.
DR   Pfam; PF00258; Flavodoxin_1; 1.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   Pfam; PF02898; NO_synthase; 1.
DR   PIRSF; PIRSF000333; NOS; 1.
DR   PRINTS; PR00369; FLAVODOXIN.
DR   PRINTS; PR00371; FPNCR.
DR   SUPFAM; SSF52343; Ferredoxin reductase-like, C-terminal NADP-linked domain; 1.
DR   SUPFAM; SSF52218; Flavoproteins; 1.
DR   SUPFAM; SSF56512; Nitric oxide (NO) synthase oxygenase domain; 1.
DR   SUPFAM; SSF63380; Riboflavin synthase domain-like; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
DR   PROSITE; PS50902; FLAVODOXIN_LIKE; 1.
DR   PROSITE; PS60001; NOS; 1.
PE   1: Evidence at protein level;
KW   Calmodulin-binding; Cytoplasm; Direct protein sequencing; FAD;
KW   Flavoprotein; FMN; Heme; Iron; Metal-binding; NADP; Oxidoreductase;
KW   Phosphoprotein; Reference proteome; Ubl conjugation; Zinc.
FT   CHAIN           1..1147
FT                   /note="Nitric oxide synthase, inducible"
FT                   /id="PRO_0000170937"
FT   DOMAIN          536..674
FT                   /note="Flavodoxin-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00088"
FT   DOMAIN          727..967
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT   REGION          22..51
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          512..532
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   MOTIF           23..27
FT                   /note="DINNN-motif; mediates interaction with SPSB1, SPSB2
FT                   and SPSB4"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         107
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="ligand shared between homodimeric partners"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         112
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="ligand shared between homodimeric partners"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         115
FT                   /ligand="(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin"
FT                   /ligand_id="ChEBI:CHEBI:59560"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         197
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         260
FT                   /ligand="L-arginine"
FT                   /ligand_id="ChEBI:CHEBI:32682"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         369
FT                   /ligand="L-arginine"
FT                   /ligand_id="ChEBI:CHEBI:32682"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         370
FT                   /ligand="L-arginine"
FT                   /ligand_id="ChEBI:CHEBI:32682"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         374
FT                   /ligand="L-arginine"
FT                   /ligand_id="ChEBI:CHEBI:32682"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         378
FT                   /ligand="(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin"
FT                   /ligand_id="ChEBI:CHEBI:59560"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         459
FT                   /ligand="(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin"
FT                   /ligand_id="ChEBI:CHEBI:59560"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         460
FT                   /ligand="(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin"
FT                   /ligand_id="ChEBI:CHEBI:59560"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         473
FT                   /ligand="(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin"
FT                   /ligand_id="ChEBI:CHEBI:59560"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         488
FT                   /ligand="heme b"
FT                   /ligand_id="ChEBI:CHEBI:60344"
FT                   /evidence="ECO:0000250|UniProtKB:P29474"
FT   BINDING         542
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         543
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         544
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         546
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         547
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         588
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         589
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         625
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         632
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         658
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         662
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000250|UniProtKB:P35228"
FT   BINDING         747
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         769
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         903
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         905
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         906
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         921
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         923
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         926
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         927
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         940
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         941
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         942
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         981
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1014
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1043
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1044
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1050
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1052
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1054
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   BINDING         1087
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:P29476"
FT   MOD_RES         564
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         572
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   CONFLICT        10
FT                   /note="R -> K (in Ref. 7; BAA07994)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        72
FT                   /note="H -> Y (in Ref. 1; BAA03138)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        107
FT                   /note="C -> R (in Ref. 3; AAC13747)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        128
FT                   /note="D -> V (in Ref. 8; BAA12035)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        130
FT                   /note="P -> H (in Ref. 3; AAC13747)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        171
FT                   /note="E -> G (in Ref. 8; BAA12035)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        195
FT                   /note="P -> S (in Ref. 8; BAA12035)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        248
FT                   /note="S -> N (in Ref. 9; AAC83553)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        248
FT                   /note="S -> T (in Ref. 3 and 5)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        264
FT                   /note="Y -> I (in Ref. 3; AAC13747)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        271
FT                   /note="D -> A (in Ref. 9; AAC83554)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        277
FT                   /note="D -> E (in Ref. 3; AAC13747)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        348
FT                   /note="A -> P (in Ref. 1; BAA03138)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        349
FT                   /note="V -> A (in Ref. 6; CAA54208)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        380
FT                   /note="F -> L (in Ref. 2, 7, 8 and 9; AAC83553/AAC83554)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        395
FT                   /note="R -> S (in Ref. 4; BAA02090)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        399
FT                   /note="E -> G (in Ref. 9; AAC83553)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        412
FT                   /note="V -> A (in Ref. 3; AAC13747)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        477
FT                   /note="M -> I (in Ref. 13)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        513
FT                   /note="T -> R (in Ref. 11; AAB18620)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        515
FT                   /note="L -> W (in Ref. 12; AAB31028)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        545
FT                   /note="G -> R (in Ref. 12; AAB31028)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        551
FT                   /note="A -> R (in Ref. 11; AAB18620)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        556
FT                   /note="A -> S (in Ref. 12; AAB31028)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        559
FT                   /note="S -> T (in Ref. 9; AAC83553/AAC83554)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        564
FT                   /note="T -> N (in Ref. 12; AAB31028)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        570
FT                   /note="E -> D (in Ref. 12; AAB31028)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        583
FT                   /note="L -> P (in Ref. 5 and 10)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        591
FT                   /note="G -> A (in Ref. 12; AAB31028)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        591
FT                   /note="G -> V (in Ref. 1 and 6)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        619
FT                   /note="A -> R (in Ref. 2; AAA85861)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        640
FT                   /note="Q -> P (in Ref. 9; AAC83553)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        664
FT                   /note="D -> G (in Ref. 11; AAB18620)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        679..680
FT                   /note="ET -> VP (in Ref. 1; BAA03138)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        690
FT                   /note="Q -> P (in Ref. 11; AAB18620)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        711
FT                   /note="S -> N (in Ref. 11; AAB18620)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        714..715
FT                   /note="SL -> TR (in Ref. 11; AAB18620)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        714
FT                   /note="S -> P (in Ref. 2, 7, 8, 9; AAC83553/AAC83554 and
FT                   10; AAC16401)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        719
FT                   /note="K -> R (in Ref. 11; AAB18620)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        721
FT                   /note="L -> P (in Ref. 6)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        722
FT                   /note="S -> R (in Ref. 1, 6 and 11)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        724..726
FT                   /note="IHA -> FLN (in Ref. 11)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        730
FT                   /note="F -> I (in Ref. 11; AAB18620)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        731
FT                   /note="T -> A (in Ref. 9; AAC83553)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        740
FT                   /note="L -> P (in Ref. 6; CAA54208)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        779
FT                   /note="A -> G (in Ref. 3; AAC13747)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        834
FT                   /note="P -> S (in Ref. 8; BAA12035)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        844
FT                   /note="A -> G (in Ref. 1; BAA03138)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        895
FT                   /note="S -> L (in Ref. 4; BAA02090)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        911
FT                   /note="Q -> L (in Ref. 3; AAC13747)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        925
FT                   /note="V -> D (in Ref. 8; BAA12035)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        937
FT                   /note="H -> N (in Ref. 9; AAC83554)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        999
FT                   /note="H -> R (in Ref. 2, 7 and 9; AAC83553/AAC83554)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1008..1009
FT                   /note="TL -> NF (in Ref. 9; AAC83554)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1016
FT                   /note="P -> R (in Ref. 5)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1016
FT                   /note="P -> S (in Ref. 8)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1017
FT                   /note="E -> R (in Ref. 5 and 8)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1024
FT                   /note="E -> K (in Ref. 9; AAC83554)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1076
FT                   /note="L -> I (in Ref. 9; AAC83553)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1084
FT                   /note="M -> I (in Ref. 6; CAA54208)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1129
FT                   /note="F -> V (in Ref. 9; AAC83554)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1133
FT                   /note="A -> V (in Ref. 2, 7 and 9; AAC83553/AAC83554)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1138
FT                   /note="T -> A (in Ref. 2, 7 and 9; AAC83553/AAC83554)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1147 AA;  130628 MW;  77C77432DD8AB0A9 CRC64;
     MACPWKFLFR VKSYQGDLKE EKDINNNVEK TPGAIPSPTT QDDPKSHKHQ NGFPQFLTGT
     AQNVPESLDK LHVTPSTRPQ HVRIKNWGNG EIFHDTLHHK ATSDISCKSK LCMGSIMNSK
     SLTRGPRDKP TPVEELLPQA IEFINQYYGS FKEAKIEEHL ARLEAVTKEI ETTGTYQLTL
     DELIFATKMA WRNAPRCIGR IQWSNLQVFD ARSCSTASEM FQHICRHILY ATNSGNIRSA
     ITVFPQRSDG KHDFRIWNSQ LIRYAGYQMP DGTIRGDPAT LEFTQLCIDL GWKPRYGRFD
     VLPLVLQAHG QDPEVFEIPP DLVLEVTMEH PKYEWFQELG LKWYALPAVA NMLLEVGGLE
     FPACPFNGWY MGTEIGVRDF CDTQRYNILE EVGRRMGLET HTLASLWKDR AVTEINAAVL
     HSFQKQNVTI MDHHTASESF MKHMQNEYRA RGGCPADWIW LVPPVSGSIT PVFHQEMLNY
     VLSPFYYYQI EPWKTHIWQD EKLRPRRREI RFTVLVKAVF FASVLMRKVM ASRVRATVLF
     ATETGKSEAL ARDLAALFSY AFNTKVVCME QYKANTLEEE QLLLVVTSTF GNGDCPSNGQ
     TLKKSLFMMK ELGHTFRYAV FGLGSSMYPQ FCAFAHDIDQ KLSHLGASQL APTGEGDELS
     GQEDAFRSWA VQTFRAACET FDVRSKHCIQ IPKRYTSNAT WEPEQYKLTQ SPESLDLNKA
     LSSIHAKNVF TMRLKSLQNL QSEKSSRTTL LVQLTFEGSR GPSYLPGEHL GIFPGNQTAL
     VQGILERVVD CSSPDQTVCL EVLDESGSYW VKDKRLPPCS LRQALTYFLD ITTPPTQLQL
     HKLARFATEE THRQRLEALC QPSEYNDWKF SNNPTFLEVL EEFPSLRVPA AFLLSQLPIL
     KPRYYSISSS QDHTPSEVHL TVAVVTYRTR DGQGPLHHGV CSTWINNLKP EDPVPCFVRS
     VSGFQLPEDP SQPCILIGPG TGIAPFRSFW QQRLHDSQHR GLKGGRMTLV FGCRHPEEDH
     LYQEEMQEMV RKGVLFQVHT GYSRLPGKPK VYVQDILQKE LADEVFSVLH GEQGHLYVCG
     DVRMARDVAT TLKKLVAAKL NLSEEQVEDY FFQLKSQKRY HEDIFGAVFS YGAKKGNTLE
     EPKGTRL
//
